Clearside Biomedical: Q3 Earnings Insights

Comments
Loading...

Clearside Biomedical CLSD reported its Q3 earnings results on Monday, November 13, 2023 at 04:05 PM.

Here's what investors need to know about the announcement.

Earnings

Clearside Biomedical reported in-line EPS of $-0.15 versus an estimate of $-0.15.

Revenue was up $593 thousand from the same period last year.

Past Earnings Performance

Last quarter the company missed on EPS by $0.01 which was followed by a 6.6% drop in the share price the next day.

Here's a look at Clearside Biomedical's past performance:

Quarter Q2 2023 Q1 2023 Q4 2022 Q3 2022
EPS Estimate -0.14 -0.14 -0.13 -0.03
EPS Actual -0.15 -0.15 -0.16 -0.13
Revenue Estimate 120K 140K 100K 6.52M
Revenue Actual 1.02M 4K 330K 266K

To track all earnings releases for Clearside Biomedical visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Market News and Data brought to you by Benzinga APIs
Date
ticker
name
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise

Posted In:
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!